Global Hemostats Market 2017-2024 - Improving Healthcare Infrastructure and Increasing Healthcare Spending - Research and Markets

DUBLIN--()--The "Global Hemostats Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024" report has been added to Research and Markets' offering.

Global hemostats market is projected to reach USD 4.5 billion by 2024 from USD 2.7 billion in 2016, at a CAGR of 6.6% in the forecast period 2017 to 2024.

Scope of the Report

  • The global hemostats market is segmented into 5 major types, namely thrombin based hemostats, combination agents, oxidized regenerated cellulose based hemostats, gelatin based haemostats and collagen based haemostats.
  • On the basis of application, the market is segmented into surgery and wound closure.
  • On the basis of end users, the market is classified into hospitals, community healthcare, ambulatory centres and clinics. In 2017, the hospital segment is expected to dominate the market and is expected to continue this trend till 2024.

Market Overview

Drivers

  • Chronic Conditions and Aging Population Leading to Increase in Number of Surgical Procedures
  • Technological Advancements
  • Increasing Number of Minimally Invasive Surgeries
  • Improving Healthcare Infrastructure and Increasing Healthcare Spending

Restraints

  • Reluctance of Surgeons Towards New Products
  • Weak Reimbursement

Opportunities

  • Unmet Medical Needs
  • Emerging Market

Challenges

  • Development of Substitute Products
  • Limitations of Hemostatic Agents in Achieving Hemostasis

Ethicon US LLC (U.S.) is dominating the hemostats market followed by Pfizer and C.R. Bard Inc., along with others such as

  • Baxter
  • Vascular Solutions, Inc.
  • B.Braun Melsungen
  • 3-D Matrix, Ltd.,
  • Resorba Medical GmbH (an Advanced Medical Solutions Group plc Company)
  • Anika Therapeutics, Inc.
  • Arch Therapeutics Inc.
  • Biom'Up SAS
  • CryoLife, Inc.
  • Gamma Therapeutics, Inc.
  • Hemostasis, LLC
  • MedTrade Products Limited, I
  • ntegra LifeSciences Corporation
  • Medline Industries, Inc.
  • HEMOTEC MEDICAL GMBH
  • Stryker
  • CSL Behring
  • Mallinckrodt
  • Equimedical, B.V.

Key Topics Covered:

1. Introduction

2. Market Segmentation

3. Market Overview

4. Premium Insights

5. Regulatory

6. Reimbursement

7. Executive Summary

8. Global Hemostats Market, by Type

9. Global Hemostats Market,By Application

10. Global Hemostats Market, by Distribution Channel

11. Global Hemostats Market, by End User

12. Global Hemostats Market, by Geography

13. Global Hemostats Market, Company Landscape

14. Company Profiles

  • 3-D Matrix, Ltd.,
  • Anika Therapeutics, Inc.
  • Arch Therapeutics Inc.
  • B.Braun Melsungen
  • Baxter
  • Biom'Up SAS
  • CryoLife, Inc.
  • CSL Behring
  • Equimedical, B.V.
  • Ethicon US LLC (U.S.)
  • Gamma Therapeutics, Inc.
  • Hemostasis, LLC
  • HEMOTEC MEDICAL GMBH
  • Mallinckrodt
  • Medline Industries, Inc.
  • MedTrade Products Limited, I
  • ntegra LifeSciences Corporation
  • Pfizer and C.R. Bard Inc.
  • Resorba Medical GmbH (an Advanced Medical Solutions Group plc Company)
  • Stryker
  • Vascular Solutions, Inc.

For more information about this report visit https://www.researchandmarkets.com/research/c7q8c5/global_hemostats.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Wound Care

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Wound Care